Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Jun 20;21(6):476-480.
doi: 10.3779/j.issn.1009-3419.2018.06.09.

[Risk Factors of Non-small Cell Lung Cancer with Bone Metastasis after Therapy]

[Article in Chinese]
Yuanshan Yao  1 , Yinjie Zhou  1 , Zhenhua Yang  1 , Haibo Shen  1
Affiliations

[Risk Factors of Non-small Cell Lung Cancer with Bone Metastasis after Therapy]

[Article in Chinese]
Yuanshan Yao et al. Zhongguo Fei Ai Za Zhi. .

Abstract
in English, Chinese

Background: Lung cancer is the leading cause of cancer-related deaths, patients with non-small cell lung cancer (NSCLC) usually have distant metastases, such as bone metastasis, brain metastasis, and lung metastasis. The purpose of this study was to explore the risk factors for bone metastasis in NSCLC patients.

Methods: A total of 176 cases of NSCLC were selected from May 2009 to May 2011, and patients were divided into two groups, namely the bone metastasis group and non-bone metastasis group. The general clinicopathological data of the two groups and analyzing the independent risk factors of bone metastasis were compared.

Results: In the general clinicopathological data of NSCLC patients. The thrombus or not and tumor-node-metastasis (TNM) stage were closely related to the occurrence of bone metastasis, and were statistically significant (all P<0.01). Prothrombin time, activated partial thromboplastin time, Fibrinogen, thrombin time, blood platelet, D-Dimer and alkaline phosphatase have significantly difference between the two groups (all P<0.05). Logistic regression analysis showed that fibrinogen, activated partial thromboplast in time, alkaline phosphatase, T4 phase, N3 phase and d-dimer were independent risk factors for bone metastasis in NSCLC patients.

Conclusions: Fibrinogen, alkaline phosphatase, T3, N2 stage and D-Dimer is the independent risk factors of bone metastases in patients with NSCLC. .

【中文题目：非小细胞肺癌患者术后发生骨转移的 危险因素】 【中文摘要：背景与目的 肺癌目前是死亡率最高的肿瘤，非小细胞肺癌（non-small cell lung cancer, NSCLC）患者在手术后通常会发生远处转移，如骨转移、脑转移、肺转移等。本研究旨在探究NSCLC患者术后发生骨转移的危险因素。方法 选择本院于2009年5月-2011年5月确诊收治的NSCLC患者176例，按照是否发生骨转移将患者分为两组，即骨转移组和无骨转移组。对比两组患者的一般临床病理资料，并通过多因素分析对比发生骨转移的独立危险因素。结果 NSCLC患者的一般临床病理资料中血栓与否，肿瘤-淋巴结-转移（tumor-node-metastasis, TNM）分期与是否发生骨转移关系密切，有统计学意义（均P<0.01）；在两组患者的凝血功能指标中发现凝血酶原时间、活化部分凝血酶活酶时间、纤维蛋白原、凝血酶时间、血小板计数、D-二聚体以及碱性磷酸酶之间存在明显的差异性，有统计学意义（均P<0.05）；Logistic回归分析发现纤维蛋白原、碱性磷酸酶、T4期、N3期和D-二聚体为NSCLC患者发生骨转移的独立危险因素。结论 纤维蛋白原、活化部分凝血酶活酶时间、碱性磷酸酶、T3期、N2期和D-二聚体为NSCLC患者发生骨转移的独立危险因素。 】 【中文关键词：肺肿瘤；骨转移；危险因素】.

Keywords: Bone metastasis; Lung neoplasms; Risk factors.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

References

    1. Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66(2):115–132. doi: 10.3322/caac.21338. - DOI - PubMed
    1. Popper HH. Progression and metastasis of lung cancer. Cancer Metastasis Rev. 2016;35(1):75–91. doi: 10.1007/s10555-016-9618-0. - DOI - PMC - PubMed
    1. Jung K, Lein M. Bone turnover markers in serum and urine as diagnostic, prognostic and monitoring biomarkers of bone metastasis. Biochim Biophys Acta. 2014;1846(2):425–438. doi: 10.1016/j.bbcan.2014.09.001. - DOI - PubMed
    1. Zhang F, Wang Y, Xu M, et al. MGr1-Ag promotes invasion and bone metastasis of small-cell lung cancer in vitro and in vivo. Oncol Rep. 2013;29(6):2283–2290. doi: 10.3892/or.2013.2396. - DOI - PubMed
    1. Taniguchi Y, Tamiya A, Nakahama K, et al. Impact of metastatic status on the prognosis of EGFR mutation-positive non-small cell lung cancer patients treated with first-generation EGFR-tyrosine kinase inhibitors. Oncol Lett. 2017;14(6):7589–7596. doi: 10.3892/ol.2017.7125. - DOI - PMC - PubMed